Evaluating drug awareness and adherence to antiglaucoma medications in patients attending Glaucoma clinic in a tertiary care hospital in South India

Tejas M. R.; Kishore M. S.; Swati R.; A. M. Satish

doi:10.5455/NJPPP.2024.v14.i11.25

2024, Vol: 14, Issue: 12

14 / 12Current Issue Online First Archive Aims and Scope Abstracting & Indexing Most Accessed Articles Most Downloaded Articles Most Cited Articles

Required files to be uploaded

NJPPP Manuscript Submission Form

« Previous Article

Original Research
Online Published: 30 Dec 2024

Natl J Physiol Pharm Pharmacol. 2024; 14(11): 2484-2491

doi: 10.5455/NJPPP.2024.v14.i11.25

Evaluating drug awareness and adherence to antiglaucoma medications in patients attending Glaucoma clinic in a tertiary care hospital in South India

Tejas M. R., Kishore M. S., Swati R., A. M. Satish.

Abstract
Background:
Glaucoma, a leading cause of blindness globally, results in progressive optic nerve damage and irreversible vision loss. In India, it accounts for a significant disease burden. Effective management requires lifelong adherence to prescribed medication regimens, yet nonadherence remains a substantial challenge.

Aim:
This study aims to evaluate the knowledge and adherence levels to antiglaucoma medication among patients with primary open angle glaucoma at KR Hospital's glaucoma clinic in Mysore.

Methods:
A cross-sectional study was conducted over three months, involving 60 glaucoma patients aged 35-70 years. Data were collected using a pre-validated questionnaire assessing drug awareness and adherence, supplemented by an eye drop instillation simulation. Descriptive and inferential statistical analyses were performed using SPSS software.

Results:
The study revealed that 98.3% of patients were aware of their medication schedules, while only 53.3% could name their prescribed medications. Adherence to medication was high, with 61.6% scoring between 8-9 on a 9-point scale. However, 46.6% of patients did not continue their medication when feeling worse. The mean awareness score was 9.397 ± 2.495, and the mean adherence score was 7.51 ± 1.29. The eye drop simulation test showed that 75% of patients scored above the mean score of 7.5.

Conclusion:
The findings indicate strong adherence and awareness regarding medication schedules but highlight gaps in knowledge about medication names and duration of treatment. Improving patient education on these aspects and adverse drug reactions is crucial. Interventions to enhance eye drop instillation techniques are necessary to optimize treatment efficacy. Addressing these issues can lead to better management of glaucoma and reduce the associated disease burden.

Key words: Adherence, Awareness, Eye drop simulation, Glaucoma Clinic, Intraocular pressure, Primary open angle glaucoma

	ARTICLE TOOLS
	Abstract
	PDF Fulltext
	How to cite this article
	Citation Tools
	Related Records
	Articles by Tejas M. R. Articles by Kishore M. S. Articles by Swati R. Articles by A. M. Satish
	on Google
	on Google Scholar

How to Cite this Article

Pubmed Style

R. TM, S. KM, R. S, Satish AM. Evaluating drug awareness and adherence to antiglaucoma medications in patients attending Glaucoma clinic in a tertiary care hospital in South India. Natl J Physiol Pharm Pharmacol. 2024; 14(11): 2484-2491. doi:10.5455/NJPPP.2024.v14.i11.25

Web Style

R. TM, S. KM, R. S, Satish AM. Evaluating drug awareness and adherence to antiglaucoma medications in patients attending Glaucoma clinic in a tertiary care hospital in South India. https://www.njppp.com/?mno=210642 [Access: January 17, 2025]. doi:10.5455/NJPPP.2024.v14.i11.25

AMA (American Medical Association) Style

R. TM, S. KM, R. S, Satish AM. Evaluating drug awareness and adherence to antiglaucoma medications in patients attending Glaucoma clinic in a tertiary care hospital in South India. Natl J Physiol Pharm Pharmacol. 2024; 14(11): 2484-2491. doi:10.5455/NJPPP.2024.v14.i11.25

Vancouver/ICMJE Style

R. TM, S. KM, R. S, Satish AM. Evaluating drug awareness and adherence to antiglaucoma medications in patients attending Glaucoma clinic in a tertiary care hospital in South India. Natl J Physiol Pharm Pharmacol. (2024), [cited January 17, 2025]; 14(11): 2484-2491. doi:10.5455/NJPPP.2024.v14.i11.25

Harvard Style

R., T. M., S., . K. M., R., . S. & Satish, . A. M. (2024) Evaluating drug awareness and adherence to antiglaucoma medications in patients attending Glaucoma clinic in a tertiary care hospital in South India. Natl J Physiol Pharm Pharmacol, 14 (11), 2484-2491. doi:10.5455/NJPPP.2024.v14.i11.25

Turabian Style

R., Tejas M., Kishore M. S., Swati R., and A. M. Satish. 2024. Evaluating drug awareness and adherence to antiglaucoma medications in patients attending Glaucoma clinic in a tertiary care hospital in South India. National Journal of Physiology, Pharmacy and Pharmacology, 14 (11), 2484-2491. doi:10.5455/NJPPP.2024.v14.i11.25

Chicago Style

R., Tejas M., Kishore M. S., Swati R., and A. M. Satish. "Evaluating drug awareness and adherence to antiglaucoma medications in patients attending Glaucoma clinic in a tertiary care hospital in South India." National Journal of Physiology, Pharmacy and Pharmacology 14 (2024), 2484-2491. doi:10.5455/NJPPP.2024.v14.i11.25

MLA (The Modern Language Association) Style

R., Tejas M., Kishore M. S., Swati R., and A. M. Satish. "Evaluating drug awareness and adherence to antiglaucoma medications in patients attending Glaucoma clinic in a tertiary care hospital in South India." National Journal of Physiology, Pharmacy and Pharmacology 14.11 (2024), 2484-2491. Print. doi:10.5455/NJPPP.2024.v14.i11.25

APA (American Psychological Association) Style

R., T. M., S., . K. M., R., . S. & Satish, . A. M. (2024) Evaluating drug awareness and adherence to antiglaucoma medications in patients attending Glaucoma clinic in a tertiary care hospital in South India. National Journal of Physiology, Pharmacy and Pharmacology, 14 (11), 2484-2491. doi:10.5455/NJPPP.2024.v14.i11.25

Author Login Reviewer Login About Publisher Editorial Policies Editorial Review Policy Peer Review Policy Editorial & Peer Review Process Publication Ethics and Publication Malpractice Statement Conflict of Interest Policy Plagiarism Policy Protection of Research Participants (Statement On Human And Animal Rights)Corrections, Retractions & Expressions of Concern Self-Archiving Policies Digital Archiving & Preservation Policies Statement of Informed Consent Advertising Policy Terms of Use License Information Copyright Information

About National Journal of Physiology, Pharmacy and Pharmacology

Contact Information

How to cite this article